IUPAC name
|
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-9-[(1S,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-14-oxo-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-9-yl]-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
|
|
IUPAC Traditional name
|
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-9-[(1S,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-14-oxo-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-9-yl]-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one
|
|
Synonyms
|
Pseudonaltrexone
|
Naltrexone Impurity
|
(5α)-(5'α)-17,17'-Bis(cyclopropylmethyl)-4,5:4',5'-diepoxy-3,3',14,14'-tetrahydroxy-[2,2'-bimorphinan]-6,6'-dione
|
|